Health and fertility in World Health Organization group 2 anovulatory women

David T. Baird; AH Balen; Héctor F. Escobar‐Morreale; J.L.H. Evers; Bart C.J.M. Fauser; S. Franks; Anna Glasier; Roy Homburg; Carlo La Vecchia; P. Devroey; K. Diedrich; L. R. Fraser; Luca Gianaroli; I. Liebaers; A. Sunde; Juha S. Tapanainen; B. Tarlatzis; A. Van Steirteghem; Anna Veiga; Pier Giorgio Crosignani; J.L.H. Evers

doi:10.1093/humupd/dms019

Abstract

1 min read

Long-term health risks in patients with WHO group 2 anovulation demand their general health be monitored, even after their reproductive needs have been fulfilled. Metabolic and cardiovascular risk prevention in women with PCOS should start as early as possible. It is not easy to analyse the possible role of PCOS, independent of obesity, metabolic syndrome, insulin resistance and diabetes, on long-term health.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Overweight and Obesity in Women: Health Risks and Consequences

Frank B Hu

Article1998

Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease.

Hannu Martikainen, Aimo Ruokonen, Hartikainen Al, Paul M Ridker

Article2017

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity

Alexessander Couto Alves, B. Valcarcel, Ville‐Petteri Mäkinen, Laure Morin‐Papunen, Sylvain Sebért, Antti J. Kangas, Pasi Soininen, Subhradip Das, Maria De Iorio, Lachlan Coin, Mika Ala‐Korpela, Paul M Ridker, S. Franks

Article2003

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance

Alexandros N. Vgontzas, Edward O. Bixler, George Chrousos

Article2020

Disorders of the glucose metabolism correlate with the phenotype and the severity in women with polycystic ovary syndrome

Josef van Helden, Osman Evliyaoğlu, Andreas Küberl, Ralf Weiskirchen